Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM). 1) BIOMARKER PRODUCTS Firalis develops BM-based diagnostic, prognostic and theranostic tools: ● RUO Kits (Research-Use-Only), based on validated innovative biomarkers ● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers 2) BIOMARKER R&D ● Development of proprietary BMs - Cardiovascular, Inflammatory, Autoimmune and Neurology ● Drug Safety & Drug Efficacy ● Patient Stratification ● Personalized Medicine 3) BIOMARKER-RELATED CRO SERVICES BM Discovery for laboratories, biotechs and pharmaceutical industry: - Proteomics: Soluble biomarker measurements with several immunoassays technologies (ELISA, multiplex and high sensitivity platforms such as Luminex® BioPlex 200™, Meso Scale Discovery®, Singulex Erenna®, Protein Simple Ella™, Olink and Siemens Dimension® EXL™ 200) - Genomics/Transcriptomics: Targeted sequencing of miRNA and mRNA (HTG EdgeSeq), lncRNA screening via Firalis proprietary platform, Next-Generation Sequencing (NGS) services (RNA-Seq, whole genome and exome sequencing, etc.) and qPCR/microfluidic qPCR (Gene Expression, SNP, CNV, etc.) - Flow Cytometry: Immunophenotyping of preclinical and clinical samples, monitoring of pharmacodynamics on target cells in response to treatment and biomarker discovery - Assay development and validation on various platforms, development of critical reagents (antibodies and proteins) - Biobanking and sample repository services supported by LIMS - Data analysis using multi-parametric statistics and development of predictive models - Support of regulatory activities related to biomarker qualification with Health Authorities (FDA/EMA) - Quality environment (ISO 9001, ISO 13485 (GMP), ISO 17025 (GLP/GCLP)) For more information please visit our website.
View Top Employees from FIRALIS S.A.Website | http://www.firalis.com |
Revenue | $5 million |
Employees | 46 (46 on RocketReach) |
Founded | 2008 |
Address | 17 Rue Du Ft, Huningue, Wallis and Futuna 68330, FR |
Phone | +41 61 795 96 20 |
Fax | +33 3 89 67 45 53 |
Technologies |
JavaScript,
HTML,
Twitter
+13 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, BIOMARKERS, Business Services, Science and Engineering, Diagnostic Equipment, CARDIOVASCULAR BIOMARKERS, Commercial, DRUG-INDUCED VASCULAR SAFETY, Health Care, DIAGNOSTIC KITS, Industrial, BIOMARKER SERVICES, BIOMARKER ASSAY DEVELOPMENT, IN-VITRO DIAGNOSTICS, SAFETY BIOMARKERS, INFLAMMATORY, PROGNOSTIC KITS, MULTIPLEX ARRAYS |
Web Rank | 18 Million |
Keywords | Firalis, "@Nanostring.Com", "@Htgmolecular.Com" |
Competitors | Augurex Life Sciences Corp., BLUEPHAGE, S.L., Biofortuna, Medicortex Finland Oyj, Savyon Diagnostics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular FIRALIS S.A. employee's phone or email?
The FIRALIS S.A. annual revenue was $5 million in 2024.
Chauvière Louis is the Head of Bioinformatics of FIRALIS S.A..
46 people are employed at FIRALIS S.A..
FIRALIS S.A. is based in Huningue, Wallis and Futuna.
The NAICS codes for FIRALIS S.A. are [54, 541713, 5417, 54171, 541].
The SIC codes for FIRALIS S.A. are [87, 873].